RADIANCE Continued Access Protocol
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 300 participants.
Also called NCT05017935
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT05017935
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05017935. Allocation not applicable; no masking; primary purpose treatment. Start 2022-05-04 (actual); primary completion 2028-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- RADIANCE Continued Access Protocol
- Acronym
- RADIANCE CAP
- Condition
- Hypertension
- Condition
- Hypertension, Resistant to Conventional Therapy
- Condition
- Vascular Diseases
- Condition
- Cardiovascular Diseases
- Intervention (Device)
- Renal Denervation
- Lead sponsor
- ReCor Medical, Inc.
Record details
- Record id
cardio:ct-nct05017935- Content hash
009fe8b558e746df54574a837ecfa19c92b989aebf80b6d83bcbc4b59fe5bc10